Cue Biopharma Stock Forecast - Price Action Indicator
| CUE Stock | USD 1.91 0.27 12.39% |
Cue Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Cue Biopharma stock prices and determine the direction of Cue Biopharma's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Cue Biopharma's historical fundamentals, such as revenue growth or operating cash flow patterns. Although Cue Biopharma's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Cue Biopharma's systematic risk associated with finding meaningful patterns of Cue Biopharma fundamentals over time.
Check out Historical Fundamental Analysis of Cue Biopharma to cross-verify your projections. Cue |
Open Interest Against 2024-05-17 Cue Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Cue Biopharma's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Cue Biopharma's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Cue Biopharma stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Cue Biopharma's open interest, investors have to compare it to Cue Biopharma's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Cue Biopharma is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Cue. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Most investors in Cue Biopharma cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Cue Biopharma's time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Cue Biopharma's price structures and extracts relationships that further increase the generated results' accuracy.
Price Action indicator evaluates an asset for a given trading period using the following formula: ((close - open) + (close - high) + (close - low)) / 2. This indicator is consistent with the interpretation of Japanese candlestick patterns.| Previous Price Action Indicator | Price Action Indicator | Trend |
| (0.18) | (0.14) |
| Check Cue Biopharma Volatility | Backtest Cue Biopharma | Information Ratio |
Cue Biopharma Trading Date Momentum
| On May 09 2024 Cue Biopharma was traded for 1.91 at the closing time. Highest Cue Biopharma's price during the trading hours was 1.91 and the lowest price during the day was 1.91 . There was no trading activity during the period 0.0. Lack of trading volume on the 9th of May did not affect price variability. The overall trading delta to current price is 14.14% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Cue Biopharma to competition |
Other Forecasting Options for Cue Biopharma
For every potential investor in Cue, whether a beginner or expert, Cue Biopharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Cue Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Cue. Basic forecasting techniques help filter out the noise by identifying Cue Biopharma's price trends.View Cue Biopharma Related Equities
| Risk & Return | Correlation |
Cue Biopharma Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Cue Biopharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Cue Biopharma's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Cue Biopharma Market Strength Events
Market strength indicators help investors to evaluate how Cue Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cue Biopharma shares will generate the highest return on investment. By undertsting and applying Cue Biopharma stock market strength indicators, traders can identify Cue Biopharma entry and exit signals to maximize returns.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.88 | |||
| Day Median Price | 1.91 | |||
| Day Typical Price | 1.91 | |||
| Price Action Indicator | (0.14) | |||
| Period Momentum Indicator | (0.27) |
Cue Biopharma Risk Indicators
The analysis of Cue Biopharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cue Biopharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cue stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.66 | |||
| Semi Deviation | 4.56 | |||
| Standard Deviation | 7.04 | |||
| Variance | 49.59 | |||
| Downside Variance | 22.5 | |||
| Semi Variance | 20.8 | |||
| Expected Short fall | (6.45) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cue Biopharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cue Biopharma's short interest history, or implied volatility extrapolated from Cue Biopharma options trading.
Pair Trading with Cue Biopharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cue Biopharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cue Biopharma will appreciate offsetting losses from the drop in the long position's value.Moving against Cue Stock
| 0.59 | HCWB | HCW Biologics | PairCorr |
| 0.52 | HOOK | Hookipa Pharma | PairCorr |
| 0.5 | VRCA | Verrica Pharmaceuticals Financial Report 14th of May 2024 | PairCorr |
| 0.45 | VIRI | Virios Therapeutics Llc | PairCorr |
The ability to find closely correlated positions to Cue Biopharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cue Biopharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cue Biopharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cue Biopharma to buy it.
The correlation of Cue Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cue Biopharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cue Biopharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cue Biopharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Historical Fundamental Analysis of Cue Biopharma to cross-verify your projections. For information on how to trade Cue Stock refer to our How to Trade Cue Stock guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Complementary Tools for Cue Stock analysis
When running Cue Biopharma's price analysis, check to measure Cue Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cue Biopharma is operating at the current time. Most of Cue Biopharma's value examination focuses on studying past and present price action to predict the probability of Cue Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cue Biopharma's price. Additionally, you may evaluate how the addition of Cue Biopharma to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
Is Cue Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cue Biopharma. If investors know Cue will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cue Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.11) | Revenue Per Share 0.12 | Quarterly Revenue Growth 11.06 | Return On Assets (0.43) | Return On Equity (0.99) |
The market value of Cue Biopharma is measured differently than its book value, which is the value of Cue that is recorded on the company's balance sheet. Investors also form their own opinion of Cue Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Cue Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cue Biopharma's market value can be influenced by many factors that don't directly affect Cue Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cue Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cue Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cue Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.